| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
7,080 |
5,269 |
$506K |
| 87631 |
|
6,036 |
4,188 |
$141K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,063 |
3,546 |
$121K |
| 87481 |
|
3,149 |
2,424 |
$93K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,393 |
3,716 |
$66K |
| 87581 |
|
4,355 |
3,007 |
$55K |
| 87486 |
|
3,888 |
2,662 |
$49K |
| 87529 |
|
1,336 |
1,121 |
$46K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,643 |
2,155 |
$42K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,301 |
858 |
$37K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,684 |
2,174 |
$29K |
| 87511 |
|
1,465 |
1,204 |
$24K |
| 87640 |
|
2,973 |
2,278 |
$21K |
| 87653 |
|
2,788 |
2,145 |
$20K |
| 87541 |
|
555 |
520 |
$10K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
62 |
59 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,754 |
2,167 |
$5K |
| 87498 |
|
12 |
12 |
$201.72 |
| 87563 |
|
1,377 |
1,039 |
$90.23 |